Royalty Pharma PLC (RPRX) SEC Filings — 2024
24 SEC filings for Royalty Pharma PLC (RPRX) in 2024.
Filings
- Royalty Pharma Files 8-K on Material Agreements — 8-K · Dec 31, 2024
- Royalty Pharma PLC SC 13G/A Filing — SC 13G/A · Nov 8, 2024
- Royalty Pharma Files 8-K on Financials — 8-K · Nov 6, 2024
- Royalty Pharma Q3 Revenue Rises to $644M — 10-Q · Nov 6, 2024
- Royalty Pharma Buys Pfizer Royalty for $2.25B — 8-K · Sep 27, 2024
- Royalty Pharma plc Files 8-K on Financials — 8-K · Aug 8, 2024
- Royalty Pharma plc Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
- Royalty Pharma plc Files 8-K Report — 8-K · Aug 7, 2024
- Royalty Pharma SC 13D/A Amendment Filed — SC 13D/A · Jul 29, 2024
- Royalty Pharma Buys J&J Tremfya Royalties for $500M — 8-K · Jun 20, 2024
- Royalty Pharma plc Files 8-K: Material Agreement & Financial Obligations — 8-K · Jun 10, 2024
- Royalty Pharma plc Files 8-K on Security Holder Votes — 8-K · Jun 6, 2024
- Royalty Pharma plc Files 8-K for Material Definitive Agreement — 8-K · Jun 4, 2024
- Royalty Pharma plc Files 8-K Report — 8-K · May 29, 2024
- Royalty Pharma plc Files 8-K on Financials — 8-K · May 9, 2024
- Royalty Pharma plc Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Royalty Pharma PLC DEF 14A Filing — DEF 14A · Apr 25, 2024
- Royalty Pharma plc Files 2023 Annual Report on Form 10-K — 10-K · Feb 15, 2024
- Royalty Pharma PLC SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Royalty Pharma PLC SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- FMR LLC & Abigail Johnson Trim Royalty Pharma Stake to 7.099% — SC 13G/A · Feb 9, 2024
- Morgan Stanley Amends Royalty Pharma Stake (SC 13G/A) — SC 13G/A · Feb 9, 2024
- Royalty Pharma Files 8-K for 'Other Event' on Feb 5, 2024 — 8-K · Feb 6, 2024
- Royalty Pharma Files 8-K on Financial Results, Exhibits — 8-K · Jan 8, 2024